These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 38559768)

  • 1. MucoRice-CTB line 19A, a new marker-free transgenic rice-based cholera vaccine produced in an LED-based hydroponic system.
    Yuki Y; Kurokawa S; Sugiura K; Kashima K; Maruyama S; Yamanoue T; Honma A; Mejima M; Takeyama N; Kuroda M; Kozuka-Hata H; Oyama M; Masumura T; Nakahashi-Ouchida R; Fujihashi K; Hiraizumi T; Goto E; Kiyono H
    Front Plant Sci; 2024; 15():1342662. PubMed ID: 38559768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative whole-genome and proteomics analyses of the next seed bank and the original master seed bank of MucoRice-CTB 51A line, a rice-based oral cholera vaccine.
    Sasou A; Yuki Y; Honma A; Sugiura K; Kashima K; Kozuka-Hata H; Nojima M; Oyama M; Kurokawa S; Maruyama S; Kuroda M; Tanoue S; Takamatsu N; Fujihashi K; Goto E; Kiyono H
    BMC Genomics; 2021 Jan; 22(1):59. PubMed ID: 33468052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MucoRice-cholera toxin B-subunit, a rice-based oral cholera vaccine, down-regulates the expression of α-amylase/trypsin inhibitor-like protein family as major rice allergens.
    Kurokawa S; Nakamura R; Mejima M; Kozuka-Hata H; Kuroda M; Takeyama N; Oyama M; Satoh S; Kiyono H; Masumura T; Teshima R; Yuki Y
    J Proteome Res; 2013 Jul; 12(7):3372-82. PubMed ID: 23763241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Good manufacturing practices production of a purification-free oral cholera vaccine expressed in transgenic rice plants.
    Kashima K; Yuki Y; Mejima M; Kurokawa S; Suzuki Y; Minakawa S; Takeyama N; Fukuyama Y; Azegami T; Tanimoto T; Kuroda M; Tamura M; Gomi Y; Kiyono H
    Plant Cell Rep; 2016 Mar; 35(3):667-79. PubMed ID: 26661780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral MucoRice-CTB vaccine for safety and microbiota-dependent immunogenicity in humans: a phase 1 randomised trial.
    Yuki Y; Nojima M; Hosono O; Tanaka H; Kimura Y; Satoh T; Imoto S; Uematsu S; Kurokawa S; Kashima K; Mejima M; Nakahashi-Ouchida R; Uchida Y; Marui T; Yoshikawa N; Nagamura F; Fujihashi K; Kiyono H
    Lancet Microbe; 2021 Sep; 2(9):e429-e440. PubMed ID: 35544149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of toxin-specific neutralizing immunity by molecularly uniform rice-based oral cholera toxin B subunit vaccine without plant-associated sugar modification.
    Yuki Y; Mejima M; Kurokawa S; Hiroiwa T; Takahashi Y; Tokuhara D; Nochi T; Katakai Y; Kuroda M; Takeyama N; Kashima K; Abe M; Chen Y; Nakanishi U; Masumura T; Takeuchi Y; Kozuka-Hata H; Shibata H; Oyama M; Tanaka K; Kiyono H
    Plant Biotechnol J; 2013 Sep; 11(7):799-808. PubMed ID: 23601492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative whole-genome analyses of selection marker-free rice-based cholera toxin B-subunit vaccine lines and wild-type lines.
    Kashima K; Mejima M; Kurokawa S; Kuroda M; Kiyono H; Yuki Y
    BMC Genomics; 2015 Feb; 16(1):48. PubMed ID: 25653106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RNAi-mediated suppression of endogenous storage proteins leads to a change in localization of overexpressed cholera toxin B-subunit and the allergen protein RAG2 in rice seeds.
    Kurokawa S; Kuroda M; Mejima M; Nakamura R; Takahashi Y; Sagara H; Takeyama N; Satoh S; Kiyono H; Teshima R; Masumura T; Yuki Y
    Plant Cell Rep; 2014 Jan; 33(1):75-87. PubMed ID: 24085308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral MucoRice-CTB vaccine is safe and immunogenic in healthy US adults.
    Yuki Y; Nojima M; Kashima K; Sugiura K; Maruyama S; Kurokawa S; Yamanoue T; Nakahashi-Ouchida R; Nakajima H; Hiraizumi T; Kohno H; Goto E; Fujihashi K; Kiyono H
    Vaccine; 2022 May; 40(24):3372-3379. PubMed ID: 35484039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Secretory IgA-mediated protection against V. cholerae and heat-labile enterotoxin-producing enterotoxigenic Escherichia coli by rice-based vaccine.
    Tokuhara D; Yuki Y; Nochi T; Kodama T; Mejima M; Kurokawa S; Takahashi Y; Nanno M; Nakanishi U; Takaiwa F; Honda T; Kiyono H
    Proc Natl Acad Sci U S A; 2010 May; 107(19):8794-9. PubMed ID: 20421480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Seed Metabolome Analysis of a Transgenic Rice Line Expressing Cholera Toxin B-subunit.
    Ogawa T; Kashima K; Yuki Y; Mejima M; Kurokawa S; Kuroda M; Okazawa A; Kiyono H; Ohta D
    Sci Rep; 2017 Jul; 7(1):5196. PubMed ID: 28701756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral MucoRice expressing double-mutant cholera toxin A and B subunits induces toxin-specific neutralising immunity.
    Yuki Y; Tokuhara D; Nochi T; Yasuda H; Mejima M; Kurokawa S; Takahashi Y; Kataoka N; Nakanishi U; Hagiwara Y; Fujihashi K; Takaiwa F; Kiyono H
    Vaccine; 2009 Oct; 27(43):5982-8. PubMed ID: 19665603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral rice-based vaccine induces passive and active immunity against enterotoxigenic E. coli-mediated diarrhea in pigs.
    Takeyama N; Yuki Y; Tokuhara D; Oroku K; Mejima M; Kurokawa S; Kuroda M; Kodama T; Nagai S; Ueda S; Kiyono H
    Vaccine; 2015 Sep; 33(39):5204-11. PubMed ID: 26254309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [MucoRice: development of rice-based oral vaccine].
    Yuki Y; Kiyono H
    Nihon Rinsho Meneki Gakkai Kaishi; 2008 Oct; 31(5):369-74. PubMed ID: 18974620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Construction of a Vibrio cholerae prototype vaccine strain O395-N1-E1 which accumulates cell-associated cholera toxin B subunit.
    Rhie GE; Jung HM; Kim BS; Mekalanos JJ
    Vaccine; 2008 Oct; 26(43):5443-8. PubMed ID: 18582519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Robust gut associated vaccine-specific antibody-secreting cell responses are detected at the mucosal surface of Bangladeshi subjects after immunization with an oral killed bivalent V. cholerae O1/O139 whole cell cholera vaccine: comparison with other mucosal and systemic responses.
    Shamsuzzaman S; Ahmed T; Mannoor K; Begum YA; Bardhan PK; Sack RB; Sack DA; Svennerholm AM; Holmgren J; Qadri F
    Vaccine; 2009 Feb; 27(9):1386-92. PubMed ID: 19146897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A rice-based oral cholera vaccine induces macaque-specific systemic neutralizing antibodies but does not influence pre-existing intestinal immunity.
    Nochi T; Yuki Y; Katakai Y; Shibata H; Tokuhara D; Mejima M; Kurokawa S; Takahashi Y; Nakanishi U; Ono F; Mimuro H; Sasakawa C; Takaiwa F; Terao K; Kiyono H
    J Immunol; 2009 Nov; 183(10):6538-44. PubMed ID: 19880451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression and functional validation of heat-labile enterotoxin B (LTB) and cholera toxin B (CTB) subunits in transgenic rice (Oryza sativa).
    Soh HS; Chung HY; Lee HH; Ajjappala H; Jang K; Park JH; Sim JS; Lee GY; Lee HJ; Han YH; Lim JW; Choi I; Chung IS; Hahn BS
    Springerplus; 2015; 4():148. PubMed ID: 25853032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression and active testing of VP7 from GCRV (Grass carp reovirus) fused with cholera toxin B subunit in rice calli.
    Zhang Q; Xu B; Pan J; Liu D; Lv R; Yan D
    Protein Expr Purif; 2019 Jun; 158():1-8. PubMed ID: 30753891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential analyses of major allergen proteins in wild-type rice and rice producing a fragment of anti-rotavirus antibody.
    Yuki Y; Kurokawa S; Kozuka-Hata H; Tokuhara D; Mejima M; Kuroda M; Oyama M; Nishimaki-Mogami T; Teshima R; Kiyono H
    Regul Toxicol Pharmacol; 2016 Apr; 76():128-36. PubMed ID: 26851506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.